Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chas Pfizer & Co Inc.filedCriticalChas Pfizer & Co Inc.
Priority to GR540116443ApriorityCriticalpatent/GR16443B/en
Publication of GR16443BpublicationCriticalpatent/GR16443B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
ία μέθοδος δια την παρασκευήν της 2-υποκατεστημένης ενώσεως της ιμιδαζολίνης, ήτις περιλαμβάνει τηνσυμπύκνωσιν μιάς ενώσεως επιλεγείσης εκ μιάς ομάδος αποτελουμένης εξ ενός καρβοξυλικού οξέος έχοντος τον τύπον (Ι) ένθα το n είναι 2 ή 3, και των εστέρων και του νιτριλίου τούτου, μετά αιθυλενοδιαμίνης.
A process for the preparation of the 2-substituted imidazoline compound, which comprises concentrating a compound selected from a group consisting of a carboxylic acid having formula (I) wherein n is 2 or 3, and its esters and nitrile, ethylenediamine.
GR540116443A1954-06-091954-06-09
PERFECTIONS IN OR IN RELATION TO CHEMICAL COMPOSITIONS AND PREPARATIONS OF THESE.
GR16443B
(en)